|
|
Molecular mechanisms of metabolic syndrome with focus on new hormones produced by adipose tissue, liver and skeletal muscle
Kloučková, Jana ; Haluzík, Martin (advisor) ; Šenolt, Ladislav (referee) ; Bužga, Marek (referee)
1 Abstract The cluster of obesity, insulin resistance and other associated comorbidities represents a significant health risk for the affected individuals as well as the whole population. Chronic low-grade inflammation of adipose tissue is considered one of the main mechanisms respon- sible for the progression from simple obesity to a fully developed metabolic syndrome. The aim of our study was to explore two different approaches that could potentially ameliorate adipose tissue inflammation - therapeutic hypothermia and the adipocytokine clusterin. In the first part, we showed that a period of deep hypothermia associated with the an- oxic phase of cardiac surgery significantly delayed the onset of systemic inflammatory re- sponse induced by surgery. The relative gene expression of the studied genes was not altered during the hypothermic period, but was significantly increased in five out of ten studied genes (IL-6, MCP-1, TNF-α, HIF1-α, GLUT1) and decreased in two genes (IRS1, GPX1) at the end of surgery. We conclude that deep hypothermia delays the onset of local adipose tissue hy- poxia and inflammation. These results could partially explain the positive effects of therapeu- tic deep hypothermia on postoperative morbidity and mortality in cardiac surgery patients. In the second part, we examined plasma...
|
|
|
The role of the gastrointestinal hormones in the control of energy homeostasis
Myšáková, Michaela ; Horáková, Olga (advisor) ; Ergang, Peter (referee)
Zachování tělesné homeostázy vyžaduje precizní komunikaci mezi všemi buňkami organismu. Velkou měrou k tomu přispívají gastrointestinální hormony, které jsou významnými signálními molekulami a podílejí se na distribuci i zpracování přijatých živin. Každý h typem buněk a jeho sekrece je regulována v závislosti na přítomnosti konkrétních nutrientů. Vzhledem rozdílné anatomii jednotlivých částí gastrointestinálního traktu, je lokalizace buněk produkujících šná. Účinky gastrointestinálních hormonů jsou rozmanité a hrají důležitou roli energetické kontrole organismu. Některé hormony (gastrin) působí jen lokálně, naproti tomu jiné (inkretiny, ghrelin) jsou zapojeny do signalizace přes centrální i periferní ne do signalizace nervové soustavy umožňuje těmto hormonům podílet se na regulaci pocitu hladu a mnoha onemocněními. V důsledku nevyváženého příjmu živin (například při nadměrném příjmu lipidů nebo sacharidů) dochází narušení některé ze složek hormonálního regulačního systému a následně vzniku onemocnění. Nejznámějšími onemocněními, vzniklými v důsledku nutriční a následně hormonální dysbalance, jsou například inzulínová rezi hormony je naprosto klíčová pro zachování lipidového metabolismu i glukózové homeostázy. Klíčová slova:
|
|
|
Metabolic specifics of women with a positive history of gestational diabetes
Jarošová, Adéla ; Vejražková, Daniela (advisor) ; Krejčí, Hana (referee)
Gestational diabetes (GDM) is a disorder of glucose metabolism arising for the first time in pregnancy and spontaneously receding after birth. The issue of GDM is very topical since, according to the latest update of diagnostic criteria, up to 17% of pregnant women is threatened by this disorder. The incidence of GDM correlates with the increasing prevalence of overweight/obesity and metabolic syndrome. It is proved that women who have had gestational diabetes have an enormously increased risk of developing type 2 diabetes mellitus (DM2T). The risk accosiated with a gestational diabetes pregnancy stretches beyond the host, and can affect the fetus both directly (e. g. macrosomia development), and epigenetically (increases susceptibility to obesity, DM2T development or cardiovascular disease). Significant influence on the development of GDM (or DM2T) is a body composition that is directly related to lifestyle (nutritional intake and physical activity) and genetic role i salso involved. Early intervention may help delay the risk of developing DM2T and other metabolic complications. In this diploma thesis we monitored metabolic profiles of glucose and lipids and body composition based on anthropometric examination and questionnaires of nutritional income and physical activity. For the complex...
|
|
|
Study of Common Pathogenetic Factors of Alzheimer Disease and Type 2 Diabetes Mellitus
Vacínová, Gabriela ; Vaňková, Markéta (advisor) ; Lukášová, Petra (referee)
Alzheimer's disease (AD) and type 2 diabetes mellitus (T2DM) are aging-associated diseases that have rising prevalence in all industrialized countries. AD is a neurodegenerative disease characterized by progressive loss of cognitive functions. It is a complex disease which formation involves both genetic factors and environmental factors. The most important marker associated with this disease is the risk allele ε4 in APOE gene. From the latest genome-wide association study emerged another ten candidate genes. As the most significant from those genes appears the minority G allele of rs744373 polymorphism in the gene BIN1. AD is connected with many metabolic and immune disorders. To the markers of interest belongs also the new parameter visfatin which can act as a pro-inflammatory cytokine. T2DM is a chronic disease characterized by raised levels of blood glucose, which is also characterized by neurological disorders. In the case of both of these diseases can be found a large number of metabolic disorders. One of the most important disorders is insulin resistance. This thesis consists of two parts - the biochemical and genetic one. The biochemical part of the thesis studies the visfatin level in patients with AD and healthly control and studies whether visfatin is related to AD. In this part of the...
|
|
|
Functional genomic and pharmacogenomic analysis of metabolic syndrome aspects
Krupková, Michaela ; Šeda, Ondřej (advisor) ; Haluzík, Martin (referee) ; Polák, Jan (referee)
Metabolic syndrome is a prevalent disease characterized by concurrent manifestation of insulin resistance, obesity, dyslipidemia, hypertension and other hemodynamic and metabolic disorders. It has multifactorial type of inheritance and its resultant phenotype is determined by both environmental and genetic factors as well as their interactions. That is the main reason why comprehensive analysis of the genetic component of this syndrome is complicated in human population. Genetically designed experimental animal models are significant tools for analysis of genetic architecture of human complex conditions including the metabolic syndrome. The aim of this Thesis is utilization of functional and comparative genomic tools to uncover pathogenesis of metabolic syndrome aspects and their genetic determinants. We also studied pharmacogenetic interactions of these genetic determinants with drugs affecting particular components of the metabolic syndrome. Establishing and utilizing several genetically designed congenic rat strains, we undertook four different research projects focusing on pharmacogenetic interaction of all-trans retinoic acid and ondansetron with differential segment of rat chromosome 8, pharmacogenetic interaction of differential segment of rat chromosome 4 and dexamethasone, determining Plzf...
|
|
|
The role of immune system in development of obesity and derived metabolic complications
Jindrová, Simona ; Bardová, Kristina (advisor) ; Cinkajzlová, Anna (referee)
Obesity is a chronic disease caused by an imbalance between energy intake and expenditure. Important source of energy is the body fat, stored in adipose tissue cells in the form of triacylglycerols. The adipose tissue does not only store triacylglycerols but also functions as an endocrine organ with the ability to secrete cytokines and adipokines - the molecules, participating in series of the metabolic proceses. The consequence of high-fat diet feeding is the growth of adipose cells and altered production od adipokines and cytokines. Majority of them have proinflammatory functions. Consequently inflammation of adipose tissue is increased as well as the activation of components of immune system, especially macrophages. The interplay between these and other aspects, including hight free fatty acid plasma levels, also associated with metabolic disorders caused by obesity, is connected with the development of insulin resistance, that means state, when the tissues are nonsensitive to insulin. Key words: obesity, adipokines, cytokines, immune system, adipose tissue, insulin resistance
|
|
|
Effect of metformin on glucose tolerance in relation to fat content in diet
Kuchaříková, Petra ; Horáková, Olga (advisor) ; Škop, Vojtěch (referee)
Prevalence of obesity and associated diseases like type 2 diabetes has increased rapidly during last years. These diseases closely relate to each other. Obesity leads to insulin resistence, which directly precedes type 2 diabetes. Metformin is the most prescribed medicament for type 2 diabetic patients and insulin resistant people. It improves glucose tolerance and insulin resistance. Enzyme AMP-activated protein kinase (AMPK) is strogly involved in metformin action. The latest studies using transgenic models lacking AMPK suggest, that notable part of mechanisms involved in metformin action is independent on AMPK. n-3 polyunsaturated fatty acids (n-3 PUFA), namely eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), which are abundant in sea fish, have beneficial effects on metabolism. These fatty acids lower plasma lipids and exert cardioprotective effects. n-3 PUFA also prevent development of insulin resistence and type 2 diabetes in rodents. The aim of this thesis was to characterise acute effects of metformin on glucose homeostasis, impact of short term diet intervention with diet rich in n-3 PUFA on metformin action and the role of insulin stimulated signalling pathways and AMPK. Results suggest that early effect of metformin is dose dependent and that single dose of metformin...
|
|
|
Central insulin signaling and phosphorylation of Tau protein in rat model of type 2 diabetes
Kasperová, Barbora Judita ; Čabala, Radomír (advisor) ; Mládková, Jana (referee)
Diabetes mellitus 2. typu (DM2) a Alzheimerova nemoc (AN) jsou jedny z nejzávažnějších nemocí naší doby. Právě DM2, spolu s obezitou a nedostatkem pohybu jsou jedny z nejrizikovějších faktorů vedoucí k poruchám kognitivních funkcí a rozvoji demence. Při rozvoji AN dochází k patologickým změnám v mozku. Dochází ke vzniku nerozpustných extracelulárních plaků amyloidního beta peptidu a hyperfosforylaci proteinu Tau. Tato bakalářská práce studuje inzulínovou signalizační kaskádu a fosforylaci proteinu Tau v hipokampech 12ti týdenních ZDF (Zucker Diabetic Fatty) potkanů, zvířecím modelu DM2, v brzkém věku života. Z inzulínové signalizační kaskády bylo detekováno signifikantně nižší množství inzulínového receptoru v hipokampech ZDF potkanů ve srovnání s kontrolami. U ostatních kinas této kaskády (PDK-1, Akt) nebyl nalezen rozdíl jak v celkovém, tak fosforylovaném/aktivovaném proteinu v hipokampech ZDF potkanů a kontrol. Rovněž u fosforylace/aktivace kinas proteinu Tau (GSK-3β, ERK, JNK) a fosforylace/aktivace proteinu Tau na několika epitopech (Ser396, Thr212, Thr231) nebyly pozorovány žádné signifikantní rozdíly mezi ZDF potkany a kontrolami. V hipokampech 12ti týdenních ZDF potkanů, ačkoliv silně hyperglykemických a obézních, nebyly zaznamenány změny v efektivitě inzulínové signalizační kaskády ani...
|
|
|
Diabetes mellitus type II in the light of metabolic syndrome
Hrnčířová, Eliška ; Rudolf, Kamil (advisor) ; Doseděl, Martin (referee)
DIABETES MELLITUS TYPE II IN THE LIGHT OF METABOLIC SYNDROME Author: Eliška Hrnčířová ¹ Tutor: MUDr. PharmDr. Kamil Rudolf, Ph.D. ¹, š ¹ Department of Clinical and Social Pharmacy, Charles University in Prague, Faculty of Pharmacy in Hradec Králové š II. intern gastroenterology clinic University Hospital Hradec Králové Background: My thesis deals with diabetes mellitus, a common chronic civilization disease, the essence of its creation, including the issue of the treatment, regime measures and it also mentions the associated health problems connected to the diagnosis. The Aim of the study: The main purpose of this work based on a small sample of patients was to verify their level of information and knowledge of the disease, compliance, participation in home blood glucose measurements and to determine the health complications associated with diabetes and its treatment. Methods: The study was carried out by questionnaire in a paper form. Data were obtained in a pharmacy during a short interview with 209 randomly selected diabetics type II. The questionnaire included two main characteristics of respondents (gender, age) and 6 simple targeted questions. Results: In the survey 59 % female and 41% male took part. The mean age of patients was 66.9 years. Respondents were diagnosed with DM on average 11.1...
|
|
|
Physiologic and pathophysiologic aspects of selected endocrinopathies. Their relationship to adipose tissue matebolism and insulin resistance
Ďurovcová, Viktória ; Kršek, Michal (advisor) ; Saudek, František (referee) ; Štich, Vladimír (referee)
The pathogenesis of insulin resistance is a complex and still intensively studied issue. Endocrine and paracrine activity of the adipose tissue together with mi- tochondrial dysfunction are the most discussed potential factors included in the development of insulin resistance. In the first part of our study we examined the involvement of the adipose tissue and its secretory products in the etiopathogenesis of insulin resistance in patients with Cushing's syndrome, acromegaly and simple obesity. We focused on three important regulators of metabolic homeostasis - fibroblast growth factors 21 and 19 (FGF-21 and FGF-19) and adipocyte fatty acid binding protein (FABP-4). We found significantly elevated circulating levels of FGF-21 and FABP-4 ac- companying insulin resistance in both patients with simple obesity and patients with obesity connected to Cushing's syndrome, as compared to healthy controls. The concentrations of both substances were comparable between hypercortisolic and obese patients. This finding together with the absence of correlation be- tween the levels of FGF-21 resp. FABP-4 and cortisol suggest that the reason for elevation of their concentrations is obesity and its metabolic consequences themselves rather then the effect of hypercortisolism on FGF-21 and FABP-4 production. We found no...
|
guest ::
